BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totalling 177,900 shares, a growth of 204.1% from the May 31st total of 58,500 shares. Currently, 2.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 216,100 shares, the short-interest ratio is currently 0.8 days.
BioNexus Gene Lab Stock Performance
Shares of BioNexus Gene Lab stock traded up $0.01 during trading hours on Friday, reaching $0.48. The company’s stock had a trading volume of 23,702 shares, compared to its average volume of 861,261. The firm has a 50 day moving average price of $0.54 and a 200-day moving average price of $0.61. BioNexus Gene Lab has a one year low of $0.31 and a one year high of $17.88.
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) last issued its quarterly earnings results on Wednesday, May 15th. The company reported ($0.02) earnings per share (EPS) for the quarter. BioNexus Gene Lab had a negative return on equity of 30.74% and a negative net margin of 27.24%. The company had revenue of $2.38 million during the quarter.
Institutional Trading of BioNexus Gene Lab
BioNexus Gene Lab Company Profile
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.
Featured Articles
- Five stocks we like better than BioNexus Gene Lab
- Transportation Stocks Investing
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.